跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,432 条关于
“copper-64”
全部
3,432
临床试验
2,261
药物
145
机构
138
资讯
888
5个月前
Clarity Pharmaceuticals Secures Large-Scale Copper-64 Manufacturing Agreement with Theragenics for Prostate Cancer Diagnostic
去年
Nusano Secures Major Supply Agreements with Ratio Therapeutics and Clarity Pharmaceuticals to Address Critical Radioisotope Shortage
去年
Clarity Pharmaceuticals Secures Major Manufacturing Deal to Scale Cu-SAR-bisPSMA Production for Prostate Cancer Diagnostics
去年
Clarity Pharmaceuticals Initiates Phase I/IIa Trial of 64Cu-SAR-bisPSMA for Metastatic Castration-Resistant Prostate Cancer
去年
Curium's SOLAR-RECUR Trial Meets Enrollment Goal for Prostate Cancer Imaging
4个月前
C-Ray Therapeutics Secures FDA Approval for Copper-64 Drug Master File, Advancing Next-Generation PET Diagnostics
3个月前
Curium, PeptiDream and PDRadiopharma Complete Patient Dosing in Phase 2 Trial of 64Cu-PSMA-I&T PET Diagnostic for Prostate Cancer in Japan
11个月前
PeptiDream, PDRadiopharma and Curium Initiate Registrational Trial for 64Cu-PSMA-I&T in Japanese Prostate Cancer Patients
去年
Curium Completes Enrollment of Phase 3 SOLAR-RECUR Prostate Cancer Trial
去年
FDA Grants Fast Track Designation to 64Cu-SAR-bisPSMA for PSMA+ Prostate Cancer Imaging
第 1 页,共 89 页
上一页
下一页